Hedge Fund Pick Mirati Rallies to Record After Drug Results

(Bloomberg) -- Mirati Therapeutics Inc., one of the most talked-about names in biotech and a frequenter of Wall Street’s M&A shopping lists, surged to a record on Monday after drug-trial results se...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.